Saturday, Sept. 10, 2022, the ESMO exam for medical oncologists will be held in the lecture hall of...

Does COVID-19 vaccination increase the risk of cancer patients undergoing therapy with immune...

Exchange and training for future leaders - that was the goal of the third TRYTRAC meeting, for which...

Joint press release by the NCT Heidelberg and the NCT/UCC Dresden

A transatlantic group of researchers at the National Center for Tumor Diseases (NCT) Heidelberg, the...

On Saturday, April 2, 2022, this year's Heidelberg CancerPatient Day was once again held as a...

The managing directorate of the National Center for Tumor Diseases (NCT) Heidelberg is expanding and...

Under the leadership of scientists from the Department of Translational Medical Oncology at the NCT...

In November 2021, the NCT Patient Advisory Board at the National Center for Tumor Diseases (NCT)...

The fellowship program of the NCT Heidelberg School of Oncology (HSO²) is aimed at young doctors and...